Intravenous Oxytocin for Recovery After Total Hip Replacement
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to test whether perioperative intravenous (IV) oxytocin compared to placebo results in faster recovery in disability as measured by daily steps over 56 days after Total Hip Arthroplasty (THA).
Who Is on the Research Team?
Douglas Ririe, M.D.
Principal Investigator
Wake Forest University School of Meidcine
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive intravenous oxytocin or placebo to assess recovery speed after Total Hip Arthroplasty
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Intravenous Oxytocin
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Oxytocin 26 micrograms administered intravenously
Placebo administered intravenously
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.